Retrospective assessment and Biologic Asthma Response Score reveal roadmap for switching biologics in severe asthma

Ann Allergy Asthma Immunol. 2024 Jan;132(1):91-93. doi: 10.1016/j.anai.2023.08.006. Epub 2023 Aug 12.

Authors

Moritz Z Kayser¹, Ben L Jülicher², Tobias Welte³, Jan Fuge³, Hendrik Suhling²

Affiliations

¹ Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany. Electronic address: kayser.moritz@mh-hannover.de.
² Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany.
³ Department of Respiratory Medicine, Hannover Medical School, Hannover, Germany; Biomedical Research in Endstage and Obstructive Lung Disease Hannover, Member of the German Center for Lung Research, Hannover, Germany.

PMID: 37580014
DOI: 10.1016/j.anai.2023.08.006

No abstract available

MeSH terms

Anti-Asthmatic Agents* / therapeutic use
Asthma* / drug therapy
Biological Products* / therapeutic use
Humans
Retrospective Studies

Substances

Anti-Asthmatic Agents
Biological Products